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Objective: This study was designed to determine whether simultaneous ante-
grade/retrograde cardioplegia improves myocardial perfusion in areas sup-
plied by occluded vessels. Methods: Isolated pig hearts placed in a Langendorff
preparation were divided into two groups. The left anterior descending
coronary artery was occluded at its origin. In group 1 (n 5 7), simultaneous
antegrade/retrograde cardioplegia was conducted with use of a single perfusion
unit with tubing in a Y-shaped configuration at the end, joined to the aorta and
the coronary sinus. In group 2 (n 5 8) simultaneous antegrade/retrograde
cardioplegia was performed with two separate units, one for antegrade delivery
of cardioplegic solution and the other for retrograde cardioplegic solution
delivery. Myocardial perfusion in the region supplied by the left anterior
descending artery and the region not supplied by this artery was assessed by
magnetic resonance imaging, with use of a magnetic resonance contrast agent.
The contrast agent was introduced into the common perfusion line in group 1
and into the aortic line only in group 2. Results: Magnetic resonance images
showed that the myocardium in the region supported by the left anterior
descending artery could not be perfused with antegrade cardioplegic solution
because of occlusion of the artery. During simultaneous antegrade/retrograde
cardioplegia, however, the myocardium in the left anterior descending region
was perfused by approximately 40% to 50% (group 1) or 20% to 30% (group 2)
of the degree of perfusion in the region not perfused by the left anterior
descending artery (100%). Almost no cardioplegic solution was delivered to the
heart through the coronary sinus route during simultaneous antegrade/
retrograde cardioplegia in both groups of hearts. Myocardial perfusion in the
region supported by the left anterior descending artery was heterogeneous
during simultaneous antegrade/retrograde cardioplegia. Conclusions: Simulta-
neous antegrade/retrograde cardioplegia significantly improved myocardial
perfusion in jeopardized areas of the myocardium. The jeopardized myocar-
dium was mainly perfused by the solution drained from the adjacent normal
tissue. Elevated pressure at the coronary sinus during simultaneous antegrade/
retrograde cardioplegia is responsible for the redistribution of antegradely
delivered cardioplegic solution. (J Thorac Cardiovasc Surg 1998;115:913-24)
Antegrade and retrograde cardioplegia are impor-tant techniques for protecting the heart during
cardiac operations.1-3 In the presence of coronary
stenosis or occlusion antegrade cardioplegia is un-
able to deliver a sufficient amount of solution to the
areas supported by the diseased artery.4-6 Because
atherosclerosis does not occur in the coronary ve-
nous system7, 8 and the coronary arterial system is
not necessarily the only outlet for cardioplegic solu-
tion delivered retrogradely,8-12 the jeopardized myo-
cardium can be perfused by retrograde delivery of
cardioplegic solution. Because of low flow,13, 14 het-
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erogeneous distribution,15 and poor supply to the
right ventricular wall,16, 17 retrograde cardioplegia
has been shown to be significantly less efficient than
antegrade cardioplegia for myocardial protection.13
On the basis of the advantages and disadvantages of
both cardioplegic techniques, it is expected that the
combination of the two techniques might become a
superior cardiac protective strategy, leading to sig-
nificant improvement in myocardial protection for
patients at high risk.18, 19 Although there are clinical
and experimental studies suggesting that simulta-
neous antegrade/retrograde cardioplegia (SARC)
provides better cardiac protection than either ante-
grade cardioplegia or retrograde cardioplegia,20, 21 it
has not been directly demonstrated that SARC
improves myocardial perfusion. Relative to ante-
grade perfusion alone, myocardial perfusion in the
healthy region is unlikely to be further improved by
simultaneous antegrade/retrograde perfusion. The
present study was aimed at determining whether
SARC improves myocardial perfusion in jeopar-
dized areas.
The concept of SARC might have originated from
the technique of intermittent occlusion of the coro-
nary sinus (IOCS). The latter has been used for
short periods as a strategy to salvage ischemic
myocardium in the beating heart and was shown to
be able to reduce infarct size and improve regional
myocardial function. However, it has not been di-
rectly demonstrated that IOCS indeed improves
myocardial perfusion. In addition, because the con-
ditions of the heart (beating vs arrested) and the
techniques used (intermittent occlusion vs continu-
ous perfusion of the coronary sinus) are different
with these two methods, the beneficial effects ob-
served with IOCS may not necessarily occur in
SARC.
Magnetic resonance (MR) imaging shows that
SARC significantly improves myocardial perfusion
in the jeopardized area of the myocardium. Inter-
estingly, almost no cardioplegic solution was deliv-
ered to the heart through the coronary sinus line
during SARC under our experimental conditions.
We speculate that elevated pressure at the coronary
sinus during SARC redistributes the solution
drained from adjacent normal tissue into the jeop-
ardized myocardium.
Material and methods
Isolated pig heart preparation. The pig was chosen as
the animal model because the venous valves and anasto-
moses in the pig heart are similar to those of the human
heart.22, 23 All animals received humane care in compli-
ance with the “Guide to the Care and Use of Experimen-
tal Animals” (first edition) formulated by the Canadian
Council on Animal Care. The protocols used in this study
were approved by the National Research Council Animal
Care Committee.
Domestic pigs weighing 45 to 55 kg were sedated with
an intramuscular injection of diazepam (5 to 10 mg) and
ketamine (25 mg). Anesthesia was maintained with 1% to
2% isoflurane in a mixture of oxygen and nitrous oxide.
The respiratory rate and volume were adjusted to keep
the arterial blood gas values within the normal physiologic
range. The brachiocephalic artery was cannulated at the
level of the common carotid artery for arterial pressure
monitoring, blood sampling, and infusion of cardioplegic
solution. A sternotomy was performed. The brachioce-
phalic and subclavian arteries were dissected. The peri-
cardium was opened longitudinally along the midline. The
ascending aorta and the main pulmonary artery were
isolated by threading umbilical tape around the origin of
the descending aorta. Anticoagulation was provided by
injection of heparin (3000 IU) into the superior vena cava.
A cannula was inserted centrally in the brachiocephalic
artery. The brachiocephalic artery, subclavian artery, de-
scending aorta, and superior and inferior venae cavae
were then clamped in succession. Heparinized cold (ap-
proximately 4° C) cardioplegic solution was infused into
the aortic root (10 ml/kg body weight). The right and left
atria were cut to allow drainage of the cardioplegic
solution and to prevent warm blood in the lungs from
returning to the heart. The heart was excised and then
mounted in a Langendorff perfusion apparatus. A hydrau-
lic occluder (IN VIVO METRIC, Healdsberg, Calif.) was
placed at the origin of the left anterior descending artery
(LAD). A 15F retrograde cannula (DLP Inc., Grand
Rapids, Mich.) with a manually inflated balloon at the tip
was positioned approximately 1 cm into the coronary sinus
and then secured with a purse-string suture. We did not
advance this cannula as far as possible because it might
have impeded effluence of antegradely perfused car-
dioplegic solution. In this study, all of the hearts showed
extension of the posterior interventricular vein. The flow
of retrograde perfusion was constantly monitored with use
of an in-line transonic flowmeter.
Perfusion solutions. Complete washout of the contrast
agent before any subsequent injection of the agent is a
prerequisite for accurate measurement of tissue perfu-
sion. The amount of blood obtained from one pig was not
sufficient to perform an imaging study. Thus in the present
study we used an oxygenated crystalloid cardioplegic
solution as the perfusion medium. The composition of this
solution was as follows (in millimoles per liter): NaCl 100,
KCl 16, MgCl2 16, ethylenediaminetetraacetic acid 0.5,
glucose 11, NaHCO3 25, KH2PO4 1.2, CaCl2 1.75, and
bovine serum albumin 0.5%. The concentration of free
calcium in this solution was 1.1 to 1.2 mmol/L. The pH of
the solution was adjusted to 7.4 to 7.5. Tepid cardioplegic
solution has been shown to improve myocardial protec-
tion during cardiac operations. We believe that this tem-
perature may combine the advantages of both hypother-
mic and normothermic cardioplegia. Therefore the
The Journal of Thoracic and
Cardiovascular Surgery
April 1998
9 1 4 Tian et al.
temperature of the heart was maintained at 30° to 31° C
throughout the protocol.
MR perfusion imaging. Myocardial perfusion was as-
sessed with MR imaging with an MR contrast agent
(gadolinium-diethylenetriamine pentaacetic acid). This
technique is noninvasive and nondestructive, such that a
heart can serve as its own control.24, 25 This technique also
offers a very high spatial resolution and is excellent for
detecting small regions of perfusion deficits.
T1-weighted MR imaging was used to assess myocardial
perfusion in this study because this imaging method
provides a higher magnitude of contrast agent–induced
Fig. 1. Top, A representative MR perfusion image acquired along the short cardiac axis from a heart with
an occluded LAD. Bottom, The same image with boundary lines defining the LAD and non-LAD regions.
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enhancement of signal intensity and has lower sensitivity
to distortion caused by the interface between the myocar-
dium and the air compared with the T2*-weighted imag-
ing method. T1-weighted imaging was performed with a 7
tesla 40 cm horizontal bore magnet and a Helmholtz
probe surrounding the whole heart. The pulse sequence to
acquire T1-weighted images was an inversion-recovery
gradient-echo with a short repetition time (10 msec) and
short echo time (4 msec). The inversion time and flip
angle of the pulse were 250 msec and 10°, respectively.
Each image covered a 15 cm2 field of view with a 128 3
128 matrix size, leading to a pixel size of 1.17 mm2. One
image was acquired every 1.25 seconds. The images were
acquired along the short axis of the heart. This orientation
of the images provides the best view of myocardial perfu-
sion throughout the heart with a single slice. Fifty images
were taken in a block. Three blocks of images were
acquired for each injection of contrast agent to follow the
dynamic changes in contrast agent level and its distribu-
tion in the myocardium. Gadolinium-diethylenetriamine
pentaacetic acid (0.05 ml/kg body weight; Berlex Canada,
Montreal, Canada) was used as the MR contrast agent.
Time courses of the signal intensity of the perfusion
images in the LAD region and the non-LAD region were
generated by averaging the signal intensities measured in
each area (Fig. 1).
Experimental protocol and procedure. The experimen-
tal protocol and setups used to perform SARC for each
group of hearts are illustrated in Fig. 2. The experimental
protocol was divided into four periods. During the first
period, the hearts were perfused antegradely with a patent
LAD. In the second period, the LAD was completely
occluded by inflating the occluder while the hearts were
still perfused antegradely. It was expected that the MR
images obtained during this period would show no perfu-
sion in the LAD region. During the third period the LAD
remained occluded and the hearts were subjected to
SARC. The hypothesis was that SARC would deliver
some cardioplegic solution to the LAD region but that
flow to this region would be much less than that to the
Fig. 2. Experimental setups for SARC (top panel) and experimental protocol (bottom panel). Antegrade,
Antegrade delivery of cardioplegic solution.
The Journal of Thoracic and
Cardiovascular Surgery
April 1998
9 1 6 Tian et al.
non-LAD region. Accordingly, the signal intensity of the
MR images was expected to be significantly lower in the
LAD region than in the non-LAD region. To show clearly
that SARC provides perfusion in the LAD region, in the
fourth period antegrade perfusion was performed without
contrast agent while the LAD remained occluded. The
purpose was to wash out the contrast agent delivered to
the non-LAD region during the previous SARC perfusion
period. It was anticipated that contrast agent in the LAD
region would remain in the area and MR images obtained
during this period were expected to show an area of high
signal intensity in the LAD region, further demonstrating
that SARC can deliver cardioplegic solution to jeopar-
dized myocardium.
In group 1 (n 5 7), SARC was performed with one
perfusion unit through Y-shaped tubing with one end
joined to the aorta and the other to the coronary sinus.
Pressure at the aorta and the coronary sinus was main-
tained at 40 to 50 mm Hg. In group 2 (n 5 8), SARC was
done with two perfusion units; one perfusion pump was
used for antegrade cardioplegia, and a saline solution bag
filled with the cardioplegic solution was used for retro-
grade cardioplegia. The pressures at the aorta and the
coronary sinus were maintained at 55 mm Hg and 38 mm
Hg, respectively. The MR contrast agent was injected into
the common line in group 1 hearts, whereas it was
administered only into the aortic line in group 2 hearts.
No contrast agent was used during the fourth period in
either group of hearts. Each period lasted 10 minutes.
During the interval between the first and second peri-
ods and the interval between the second and third periods,
the LAD occluder was released for 5 minutes to wash out
Fig. 3. Representative MR images acquired during antegrade cardioplegic solution delivery (second
period) and during SARC from a group 1 heart (top images) and a group 2 heart (bottom images). No
perfusion is seen in the LAD region during antegrade cardioplegic solution delivery (second period)
whereas myocardium in the LAD region was partially perfused by SARC in both hearts.
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Fig. 4. Representative MR images obtained during antegrade perfusion with no contrast agent (fourth
period) immediately after SARC in a group 1 heart (top image) and a group 2 heart (bottom image). The
images show retention of contrast agent in the LAD region, indicating that this part of myocardium was
perfused during SARC. LV, Left ventricle.
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the contrast agent delivered during the previous injection
as well as to minimize any possible injury to the coronary
vessels in the region. MR images were continuously
acquired during these intervals to ensure the removal of
all contrast agent from the heart before the subsequent
injection.
Statistical analyses. Statistical analyses were per-
formed with STATISTICA computer software (STAT-
SOFT Inc., Tulsa, Okla.). All results are expressed as the
mean plus or minus the standard error of the mean.
Comparison of the time course of signal intensity from the
LAD and non-LAD regions was performed by one-way
analysis of variance with repeated measurements. One-
way analysis of variance was also used to compare the
maximum signal intensity obtained from the LAD region
during various stages of the protocol. The distribution of
cardioplegic solution in the LAD region during SARC was
determined using EvIdent two- and three-dimensional
image analysis software (Institute for Biodiagnostics,
NRC, Winnipeg, Canada).
Results
Fig. 3 shows representative images obtained from
groups 1 (top images) and 2 (bottom images) during
antegrade delivery of cardioplegic solution (second
period) and SARC (third period) with an occluded
LAD. As expected, the images acquired from both
groups during the second period (Fig. 3, left) show
no contrast agent in the LAD region, indicating that
no perfusion occurred in this area during antegrade
cardioplegic solution delivery with the LAD oc-
cluded. The images obtained during SARC show
penetration of contrast agent into the LAD region
(Fig. 3, right). This suggests that SARC delivers
cardioplegic solution to the jeopardized areas of the
myocardium. Furthermore, Fig. 4 shows representa-
tive images obtained during antegrade perfusion
(fourth period) with the LAD occluded after SARC.
No contrast agent was used during this imaging
period to wash out contrast agent in the non-LAD
regions administered in the previous steps. The
images obtained during the fourth period show that
contrast agent remained in the LAD region. This
further demonstrates that the myocardium supplied
by an occluded coronary artery can be perfused with
the use of SARC.
In addition, in group 1 hearts the pressure values
in the aorta and at the coronary sinus were similar
when the coronary sinus balloon was fully inflated:
46.6 6 3.2 mm Hg in the aorta and 46.7 6 2.9 mm
Hg in the coronary sinus.
Fig. 5 summarizes myocardial perfusion during
antegrade delivery of cardioplegic solution (second
period, top panel) and SARC (third period, middle
panel) in the LAD and the non-LAD regions in
group 1 hearts. During antegrade perfusion (second
period), signal intensity in the LAD region re-
mained almost unchanged whereas signal intensity
in the non-LAD region showed a rapid and signifi-
cant increase (p , 0.001), indicating that the myo-
cardium in the LAD region was virtually not per-
fused. During SARC (Fig. 5, middle panel), injection
of contrast agent resulted in an increase of signal
intensity in both regions, although the magnitude of
signal intensity increase was significantly smaller in
the LAD region than in the non-LAD region (p ,
0.001). SARC resulted in a significant increase of
Fig. 5. Time courses of signal intensity from the LAD
and non-LAD regions in group 1 hearts during antegrade
cardioplegic solution delivery (second period, top panel)
and SARC (middle panel). The time courses of signal
intensity from the LAD region during antegrade cardio-
plegia and SARC are shown in the bottom panel.
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signal intensity in the LAD region compared with
that during antegrade cardioplegia (p , 0.001)
(bottom panel). Although contrast agent was admin-
istered only into the aortic line in group 2 hearts,
similar results were obtained and are shown in Fig. 6.
Comparisons of contrast agent–induced maxi-
mum signal intensity obtained during antegrade
delivery of cardioplegic solution (second period)
and SARC (third period) from the LAD region and
the non-LAD regions are shown in Fig. 7. Maximum
signal intensity from the non-LAD region was set as
100%. During antegrade cardioplegia, maximum
signal intensity in the LAD region was 3.54% 6
0.59% of that in the non-LAD region, which may be
attributed to baseline noise. This suggests that al-
most no solution was delivered to the LAD region
during antegrade perfusion in the presence of LAD
occlusion. The maximum signal intensity in the LAD
region was significantly higher (p , 0.001) during
SARC (34.6% 6 5.7%, combination of groups 1 and
2) than during antegrade cardioplegia (second pe-
riod, 3.54% 6 0.59%), indicating that the LAD-
supported myocardium was being perfused by
SARC. Furthermore, maximum signal intensity in
the LAD region during SARC was significantly
higher in group 1 hearts (47.3% 6 8.6%) than in
group 2 hearts (23.46% 6 5.2%) (p 5 0.002),
suggesting that pressure at the coronary sinus (rel-
ative to the pressure at the aorta) is an important
factor in determining the flow of SARC solution to
the jeopardized myocardium.
Interestingly, we found that no solution was de-
livered to the heart through the coronary sinus
during SARC in group 2 hearts. In group 1, five
hearts received no solution through the coronary
sinus during SARC. Retrograde flow to the remain-
ing two hearts was also extremely low (1 to 10
ml/min).
Representative patterns of cardioplegic distribu-
tion in the LAD region obtained during SARC are
shown in Fig. 8. All the hearts in both groups
showed heterogeneous perfusion to the occluded
myocardium during SARC.
Discussion
SARC through various routes has been proposed
as a superior technique for heart protection during
cardiac operations, in particular for patients at high
risk.18-21 However, it has not been directly demon-
strated that SARC does indeed improve myocardial
perfusion. It is also unclear whether the heart is
perfused through the aorta and the coronary sinus
simultaneously or only through the aorta during
SARC. The present study was therefore conducted
to answer these questions. We found that SARC
significantly improved myocardial perfusion in the
occluded myocardium and that under our experi-
mental conditions no solution could be delivered to
the heart through the retrograde line, suggesting
that the improvement in myocardial perfusion with
SARC was most likely a result of the increase in
coronary sinus pressure.
In the hearts in group 1 SARC produced an
Fig. 6. Time courses of signal intensity from the LAD
and non-LAD regions in group 2 hearts during antegrade
cardioplegic solution delivery (second period, top panel)
and SARC (middle panel). The time courses of signal
intensity from the LAD region during antegrade cardio-
plegia and SARC are shown in the bottom panel.
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increase in the maximum signal intensity in the LAD
region (47.3% 6 8.6%) relative to that observed in
the non-LAD region (100%) (Fig. 7). Because it
may not depend solely on the coronary flow, the
maximum signal intensity cannot be used as a pre-
cise measurement of myocardial flow rate. On the
other hand, comparison of the maximum signal
intensity between the two regions was made in the
same hearts. Other factors (which may have an
impact on the maximum signal intensity, such as
blood vessel volume and permeability) are expected
to be comparable in these two regions. Accordingly,
the ratio of the maximum signal intensity in two
regions could be considered as an approximation of
the ratio of myocardial flow. Based on the maximum
signal intensity, myocardial flow resulting from
SARC to the jeopardized myocardium is approxi-
mately 40% to 50% of that to the non-LAD region.
The results demonstrate that SARC significantly
improves myocardial perfusion in the jeopardized
areas. On the other hand, the data also show that
SARC provides heterogeneous perfusion within the
occluded region (Fig. 8).
In addition, we found that pressure values in the
aorta (46.8 6 3.2 mm Hg) and coronary sinus
(46.7 6 2.9 mm Hg) were similar during SARC in
group 1 hearts, if there was no solution leakage at
the coronary sinus. We also found that the pressure
values in the coronary sinus and retrograde flow
during SARC were highly dependent on balloon
inflation. If the balloon was fully inflated and the
orifice of the coronary sinus was completely sealed,
there was no solution leakage in the coronary sinus.
Under these conditions, coronary sinus pressure
reached a maximum and the retrograde flow was
almost zero (five hearts showed no retrograde flow
and two showed a flow rate of 1 to 10 ml/min). This
suggests that during SARC the myocardium in the
LAD region was not perfused by the solution deliv-
ered through the retrograde line. It is our hypothesis
that during SARC the myocardium at risk is mainly
perfused by the solution delivered antegradely and
drained from the adjacent tissue as a result of
elevated pressure at the coronary sinus.
To test our hypothesis and to determine the effect
of pressure at the coronary sinus during SARC on
perfusion of the myocardium at risk, we studied the
second group of hearts. In this group, contrast agent
Fig. 7. Comparison of the maximum signal intensity obtained from the LAD region and the non-LAD
region during the second and third periods.
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was introduced only into the aortic line during
SARC. Retrograde perfusion of SARC was per-
formed with use of a saline solution bag filled with
cardioplegic solution and joined to the retrograde
cannula to set the coronary sinus pressure to the
designed levels. In this group, coronary sinus pres-
sure was controlled at 38 mm Hg and the aortic
pressure was maintained at 55 mm Hg. Under these
conditions, we found that no solution was delivered
to the heart through the retrograde cannula during
SARC. However, MR images still show invasion of
MR contrast agent into the LAD region during
SARC (Figs. 3, 4, 6, and 7) although no contrast
agent was administered into the retrograde line.
This further demonstrates that the myocardium in
occluded areas is mainly perfused by the solution
drained from the adjacent normal tissue, not by
solution delivered retrogradely.
Furthermore, MR images show that myocardial
perfusion in the LAD region was significantly less in
group 2 hearts than in group 1 hearts (23.46% 6
5.29% vs 47.3% 6 8.6%, p 5 0.002), suggesting that
pressure at the coronary sinus relative to the aortic
pressure may play an important role in determining
the flow of SARC solution to the risk areas of the
myocardium. We are currently testing whether a
higher pressure in the coronary sinus relative to that
in the aorta will further improve myocardial perfu-
sion. In addition, maximum signal intensity in the
non-LAD region from group 1 hearts was signifi-
cantly higher (p 5 0.024) during SARC than during
antegrade delivery of cardioplegic solution, even
though total flow and amount of contrast agent used
were identical during these two periods. At present,
it is still uncertain whether higher maximum signal
intensity in the non-LAD region during SARC relative
to that during antegrade perfusion was caused by
improved perfusion or other unknown factors.
In addition, with use of our two- and three-dimen-
sional image analysis software (EvIdent), we have
demonstrated in this study that SARC does not pro-
vide homogeneous perfusion to the jeopardized myo-
cardium. In the clinical situation, however, the size of
the area at risk caused by coronary stenosis or occlu-
sion is usually much smaller than that used in this
study. Heterogeneous perfusion of SARC, therefore,
may not be so pronounced in the human heart.
It must be pointed out that the present study was
performed on isolated pig hearts. The subjects were
healthy and relatively young. It is possible that the
development of coronary anastomoses and thebes-
ian vessels is much less in the pig heart than in the
Fig. 8. A representative perfusion pattern in the LAD region during SARC. Three areas in the LAD
region were identified according to their perfusion pattern (top images). The bottom graphs show the
average time courses of signal intensity obtained from the corresponding areas. AU, Arbitrary units.
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human patient heart. Consequently, the capacity of
SARC to perfuse the area at risk may be higher in
the human being than it is in the pig. In addition,
this study did not compare SARC with other cardio-
protective techniques (such as antegrade cardiople-
gia, retrograde cardioplegia, and alternate ante-
grade/retrograde cardioplegia) in terms of their
effects on myocardial energy metabolism and func-
tional recovery. Moreover, the potential detrimental
effect of SARC on the coronary vasculature was not
evaluated in this study. Therefore, at the present, no
judgment can be made regarding which technique is
superior for heart protection. As mentioned previ-
ously, this study was done with the use of crystalloid
solution because of the insufficient blood volume
that was obtainable from the animal. Because of
intrinsic physiologic characteristics of blood, we
expect that our study would be more clinically
relevant if it had been performed with blood car-
dioplegic solution.
Clinically, some surgeons use antegrade delivery
of cardioplegic solution through a newly established
vein bypass graft while cardioplegic solution is still
being delivered retrogradely through the coronary
sinus. This combination has been used to test vas-
cular anastomoses and to improve myocardial per-
fusion in the territory supported by the grafted
artery. This is a practical and interesting combina-
tion of both antegrade and retrograde cardioplegia.
However, because the conditions of this combina-
tion and those of SARC used in our study are very
different, it is expected that these two techniques
would result in different myocardial perfusion.
In summary, this study demonstrates that SARC
improves myocardial perfusion to the areas of the
myocardium at risk. However, under our experimen-
tal conditions, almost no solution is delivered to the
heart through the coronary sinus. The myocardium
at risk is mainly perfused by the solution drained
from adjacent normal tissue during SARC. Elevated
pressure in the coronary sinus seems to be the
principal factor responsible for improved perfusion
of the myocardium at risk.
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